⌘K

Login Start Free

Home/Filings/4/0001127602-23-014745

4//SEC Filing

LeCointe-Cephas Lisa 4

Accession 0001127602-23-014745

CIK 0000310158other

View on SEC.gov Company Profile

Filed

May 4, 8:00 PM ET

Accepted

May 5, 5:01 PM ET

Size

13.5 KB

Accession

0001127602-23-014745

Insider Transaction Report

Form 4

Period: 2023-05-03

Merck & Co., Inc.MRK

LeCointe-Cephas Lisa

SVP Chief Ethics & Com Officer

Transactions

Exercise/Conversion
Common Stock
2023-05-03$117.89/sh+689$81,226→ 4,843.693 total
Tax Payment
Common Stock
2023-05-03$117.89/sh−236$27,822→ 4,607.693 total
Exercise/Conversion
Common Stock
2023-05-04$118.22/sh+813$96,113→ 5,420.693 total
Tax Payment
Common Stock
2023-05-04$118.22/sh−279$32,983→ 5,141.693 total
Exercise/Conversion
Restricted Stock Unit
2023-05-03−689→ 1,378 total
From: 2023-05-03Exp: 2025-05-03→ Common Stock (689 underlying)
Exercise/Conversion
Restricted Stock Unit
2023-05-04−813→ 816 total
From: 2022-05-04Exp: 2024-05-04→ Common Stock (813 underlying)

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
[F2]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024, and 5/3/2025.
[F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1

filerCIK 0001854644

Filing Metadata

Form type: 4
Filed: May 4, 8:00 PM ET
Accepted: May 5, 5:01 PM ET
Size: 13.5 KB

View on SEC.gov